13 results

• Class Action Lawsuit Over Celebrex, Bextra Heart Problems Revived For Shareholders

  April 13, 2016

  Irvin Jackson

  A federal appeals court has revived a class action lawsuit against Pfizer by shareholders who say the company hid health risks linked to Celebrex and Bextra, artificially inflating its stock value.

• Doctors Influenced By Kickbacks, Overprescribe Painkillers, Studies Show

  August 8, 2013

  Irvin Jackson

  Confusion over back pain treatment guidelines and illegal kickbacks may be leading to overprescription by doctors

• Bextra, Celebrex Class Action Lawsuit for Investors Certified

  April 2, 2012

  Staff Writers

  A federal judge has granted class action status to an investor lawsuit brought against Pfizer over claims the company lied...

• Proposed Avandia Settlement Would Pay U.S. $3B for Off-Label Marketing

  November 7, 2011

  Staff Writers

  GlaxoSmithKline and the federal government have reached a tentative $3 billion settlement over Avandia marketing charges, alleging that the company...

• Dilantin Stevens-Johnson Syndrome Lawsuit Filed by Three People

  January 20, 2011

  Staff Writers

  A Stevens-Johnson syndrome lawsuit has been filed in Illinois against the makers of the epilepsy drug Dilantin, by two people...

• Drug Companies Top Other Industries in Federal Fraud Lawsuits: Report

  December 28, 2010

  Staff Writers

  The pharmaceutical industry leads the way in committing fraud against the U.S. government, according to the findings of a study...

• FDA Bans KV Pharmaceuticals CEO from Industry

  November 18, 2010

  Staff Writers

  In a move that may signal an increasing willingness to get tough on pharmaceutical company executives, federal regulators have banned...

• DOJ to Intervene in Rapamune Whistleblower Lawsuit Against Pfizer

  September 22, 2010

  Staff Writers

  The federal government and a number of states have decided to intervene in a whistleblower lawsuit that accuses Pfizer’s Wyeth...

• Pfizer Faces Criminal Investigation Over Rapamune Marketing

  March 9, 2010

  Staff Writers

  Federal prosecutors have opened a criminal investigation into Wyeth’s promotions and marketing activities involving the organ transplant drug Rapamune.

• Drug Maker Sues FDA Over Ban on Offering Doctors Info About Off-Label Uses

  October 5, 2009

  AboutLawsuits

  The makers of Botox filed a lawsuit last week against the FDA, challenging federal regulations that ban drug companies from...